Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Xiao-qiang Chai"'
Autor:
Zhong-Chen Li, Jie Wang, He-Bin Liu, Yi-Min Zheng, Jian-Hang Huang, Jia-Bin Cai, Lei Zhang, Xin Liu, Ling Du, Xue-Ting Yang, Xiao-Qiang Chai, Ying-Hua Jiang, Zheng-Gang Ren, Jian Zhou, Jia Fan, De-Cai Yu, Hui-Chuan Sun, Cheng Huang, Feng Liu
Publikováno v:
Cell Reports, Vol 43, Iss 3, Pp 113877- (2024)
Summary: Combination therapy (lenvatinib/programmed death-1 inhibitor) is effective for treating unresectable hepatocellular carcinoma (uHCC). We reveal that responders have better overall and progression-free survival, as well as high tumor mutation
Externí odkaz:
https://doaj.org/article/373fb5f605da44d19f76ab1177c0032c
Autor:
Chao Gao, Si-wei Wang, Jia-cheng Lu, Xiao-qiang Chai, Yuan-cheng Li, Peng-fei Zhang, Xiao-yong Huang, Jia-bin Cai, Yi-min Zheng, Xiao-jun Guo, Guo-ming Shi, Ai-wu Ke, Jia Fan
Publikováno v:
Biomarker Research, Vol 10, Iss 1, Pp 1-19 (2022)
Abstract Background Kinase suppressor of Ras 2 (KSR2) is a regulator of MAPK signaling that is overactivated in most hepatocellular carcinoma (HCC). We sought to determine the role of KSR2 in HCC pathogenesis. Methods We tested the level of KSR2 in H
Externí odkaz:
https://doaj.org/article/1420ed705a324cb1a2f47b22f124007a
Autor:
Jian-Hang Huang, Jie Wang, Xiao-Qiang Chai, Zhong-Chen Li, Ying-Hua Jiang, Jun Li, Xing Liu, Jia Fan, Jia-Bin Cai, Feng Liu
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 5 (2022)
ABSTRACT Microbiota is implicated in hepatocellular carcinoma (HCC). The spectrum of intratumoral microbiota associated with HCC progression remains elusive. Fluorescence in situ hybridization revealed that microbial DNAs were distributed in the cyto
Externí odkaz:
https://doaj.org/article/3e4ce8347ddb4d768ea08894da352306
Autor:
Chuan-Yuan Wei, Meng-Xuan Zhu, Peng-Fei Zhang, Xiao-Yong Huang, Jin-Kai Wan, Xiu-Zhong Yao, Ze-Tao Hu, Xiao-Qiang Chai, Rui Peng, Xuan Yang, Chao Gao, Jian Gao, Si-Wei Wang, Yi-Min Zheng, Zheng Tang, Qiang Gao, Jian Zhou, Jia-Bin Cai, Ai-Wu Ke, Jia Fan
Publikováno v:
Journal of Hepatology. 78:881-882
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3730d0637d93c2d7f31d8948521a7246
https://doi.org/10.1016/j.jhep.2022.11.004
https://doi.org/10.1016/j.jhep.2022.11.004
Autor:
Chao Gao, Si-wei Wang, Jia-cheng Lu, Xiao-qiang Chai, Yuan-cheng Li, Peng-fei Zhang, Xiao-yong Huang, Jia-bin Cai, Yi-min Zheng, Xiao-jun Guo, Guo-ming Shi, Ai-wu Ke, Jia Fan
Publikováno v:
Biomarker research. 10(1)
Background Kinase suppressor of Ras 2 (KSR2) is a regulator of MAPK signaling that is overactivated in most hepatocellular carcinoma (HCC). We sought to determine the role of KSR2 in HCC pathogenesis. Methods We tested the level of KSR2 in HCC tissue
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b437c39e575d18f9e193b5815d7ecc4b
https://pubmed.ncbi.nlm.nih.gov/35468812
https://pubmed.ncbi.nlm.nih.gov/35468812
Autor:
Chuan-Yuan Wei, Meng-Xuan Zhu, Peng-Fei Zhang, Xiao-Yong Huang, Jin-Kai Wan, Xiu-Zhong Yao, Ze-Tao Hu, Xiao-Qiang Chai, Rui Peng, Xuan Yang, Chao Gao, Jian Gao, Si-Wei Wang, Yi-Min Zheng, Zheng Tang, Qiang Gao, Jian Zhou, Jia-Bin Fan, Ai-Wu Ke, Jia Fan
Publikováno v:
Journal of hepatology. 77(1)
Despite remarkable advances in treatment, most patients with hepatocellular carcinoma (HCC) respond poorly to anti-programmed cell death 1 (anti-PD1) therapy. A deeper insight into the tolerance mechanism of HCC against this therapy is urgently neede
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20eca3218c0c97d7b92f3d3116a4bff3
https://pubmed.ncbi.nlm.nih.gov/36564318
https://pubmed.ncbi.nlm.nih.gov/36564318